Showing results (31-40 of 43) with videos related to
Sort By:
Pageof 5
International Journal of Clinical Practice|December 31, 2009
STEP: simplified treatment of the enlarged prostateM T Rosenberg, M M Miner, P A Riley, et al.British Medical Journal|June 2, 1973
Early endoscopy of oesophagus, stomach, and duodenal bulb in patients with haematemesis and melaenaP B Cotton, M T Rosenberg, R P Waldram, et al.International Journal of Impotence Research|December 24, 2010
Stopwatch-assessed duration of erection: a new measure of the efficacy of erectile dysfunction treatmentsM T Rosenberg, M M Miner, A L Barnes, et al.Urology|July 3, 2003
Early changes of oxalate and calcium urine excretion in those with calcium oxalate stone formation after extracorporeal shock wave lithotripsyS Oehlschläger, S Albrecht, O W Hakenberg, et al.Luminescence : the Journal of Biological and Chemical Luminescence|May 11, 2002
Measurement of free radicals and NO by chemiluminescence to identify the reperfusion injury in renal transplantationS Oehlschläger, S Albrecht, O W Hakenberg, et al.International Journal of Clinical Practice|August 20, 2013
Complex cases in primary care: report of a CME-certified series addressing patients with multiple comorbiditiesK Andolsek, M T Rosenberg, M Abdolrasulnia, et al.Urologia Internationalis|December 13, 2001
Relationship of comorbidity, age and perioperative complications in patients undergoing radical prostatectomyM Froehner, R Litz, A Manseck, et al.International Journal of Clinical Practice|November 26, 2009
Trospium chloride once-daily extended release is effective and well tolerated for the treatment of overactive bladder syndrome: an integrated analysis of two randomised, phase III trialsD R Staskin, M T Rosenberg, P K Sand, et al.International Journal of Clinical Practice|November 7, 2007
Effects of oxybutynin transdermal system on health-related quality of life and safety in men with overactive bladder and prostate conditionsD R Staskin, M T Rosenberg, N V Dahl, et al.International Journal of Clinical Practice|January 8, 2009
Improvement in duration of erection following phosphodiesterase type 5 inhibitor therapy with vardenafil in men with erectile dysfunction: the ENDURANCE studyM T Rosenberg, P L Adams, T A McBride, et al.Pageof 5